PureTech Adds Inflammatory Disease Candidates To Pipeline With Alivio Buyout
Four years after launching Alivio Therapeutics, PureTech Health plc (NASDAQ:PRTC) is bringing the hydrogel player back into the fold by acquiring the…
PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics
PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated